- All sections
- C - Chemistry; metallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 235/12 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
Patent holdings for IPC class C07C 235/12
Total number of patents in this class: 101
10-year publication summary
6
|
11
|
7
|
2
|
10
|
10
|
7
|
3
|
5
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Arcturus Therapeutics, Inc. | 164 |
11 |
Daikin Industries, Ltd. | 9838 |
5 |
BioTheryX, Inc. | 100 |
5 |
Theravance Biopharma R&D IP, LLC | 517 |
5 |
Bezwada Biomedical, LLC | 48 |
4 |
Otsuka Pharmaceutical Factory, Inc. | 300 |
4 |
F. Hoffmann-La Roche AG | 7942 |
3 |
Adabio Co.,Ltd. | 7 |
3 |
BASF SE | 20432 |
2 |
DSM IP Assets B.V. | 5802 |
2 |
CJ Cheiljedang Corporation | 3256 |
2 |
Coöperatie Koninklijke Cosun U.A. | 79 |
2 |
Heptares Therapeutics Limited | 118 |
2 |
Osaka Prefecture University Public Corporation | 249 |
2 |
Stella Pharma Corporation | 37 |
2 |
University of Prince Edward Island | 61 |
2 |
Victoria Link Limited | 181 |
2 |
Resonac Corporation | 2423 |
2 |
Sanofi-Aventis Deutschland GmbH | 2602 |
1 |
Merck Patent GmbH | 5842 |
1 |
Other owners | 39 |